Elevated serum manganese superoxide dismutase in acute leukemias
We measured the serum levels of manganese-superoxide dismutase (Mn-SOD) in acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL). Serum Mn-SOD level for normal subjects was 94.1 ± 23.5 ng/ml (mean ± S.D.), the levels for AML and ALL patients were 159.6 ± 77.1 ng/ml and 154.4 ± 77.0 ng/ml, r...
Saved in:
Published in | Cancer letters Vol. 62; no. 3; pp. 211 - 215 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Shannon
Elsevier Ireland Ltd
15.03.1992
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | We measured the serum levels of manganese-superoxide dismutase (Mn-SOD) in acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL). Serum Mn-SOD level for normal subjects was 94.1 ± 23.5 ng/ml (mean ± S.D.), the levels for AML and ALL patients were 159.6 ± 77.1 ng/ml and 154.4 ± 77.0 ng/ml, respectively. The serum Mn-SOD levels were unrelated to individual intracellular Mn-SOD levels, but correlated well with serum lactate dehydrogenase values. Regression of the leukemia was accompanied by decrease in the serum level of Mn-SOD. Serum Mn-SOD may thus serve as a measure of the activity of the disease. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0304-3835 1872-7980 |
DOI: | 10.1016/0304-3835(92)90098-G |